EAM
Eventide Asset Management’s Crinetics Pharmaceuticals CRNX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-609,014
| Closed | -$31.1M | – | 227 |
|
|
2024
Q4 | $31.1M | Sell |
609,014
-126,074
| -17% | -$6.45M | 0.57% | 62 |
|
|
2024
Q3 | $37.6M | Hold |
735,088
| – | – | 0.65% | 52 |
|
|
2024
Q2 | $32.9M | Sell |
735,088
-324,545
| -31% | -$14.5M | 0.56% | 58 |
|
|
2024
Q1 | $49.6M | Hold |
1,059,633
| – | – | 0.78% | 46 |
|
|
2023
Q4 | $37.7M | Buy |
1,059,633
+40,851
| +4% | +$1.45M | 0.62% | 56 |
|
|
2023
Q3 | $30.3M | Buy |
1,018,782
+584,014
| +134% | +$17.4M | 0.54% | 55 |
|
|
2023
Q2 | $7.83M | Hold |
434,768
| – | – | 0.13% | 124 |
|
|
2023
Q1 | $6.98M | Buy |
+434,768
| New | +$6.98M | 0.13% | 124 |
|
|
2021
Q2 | – | Sell |
-241,140
| Closed | -$3.69M | – | 154 |
|
|
2021
Q1 | $3.69M | Sell |
241,140
-158,860
| -40% | -$2.43M | 0.05% | 139 |
|
|
2020
Q4 | $5.64M | Sell |
400,000
-947,000
| -70% | -$13.4M | 0.09% | 121 |
|
|
2020
Q3 | $21.1M | Hold |
1,347,000
| – | – | 0.41% | 70 |
|
|
2020
Q2 | $23.6M | Buy |
1,347,000
+400,000
| +42% | +$7.01M | 0.51% | 62 |
|
|
2020
Q1 | $13.9M | Hold |
947,000
| – | – | 0.45% | 65 |
|
|
2019
Q4 | $23.8M | Hold |
947,000
| – | – | 0.67% | 59 |
|
|
2019
Q3 | $14.2M | Buy |
947,000
+143,161
| +18% | +$2.15M | 0.47% | 67 |
|
|
2019
Q2 | $20.1M | Buy |
803,839
+419,839
| +109% | +$10.5M | 0.61% | 60 |
|
|
2019
Q1 | $8.74M | Buy |
384,000
+260,775
| +212% | +$5.94M | 0.3% | 75 |
|
|
2018
Q4 | $3.7M | Hold |
123,225
| – | – | 0.16% | 92 |
|
|
2018
Q3 | $3.53M | Buy |
+123,225
| New | +$3.53M | 0.13% | 106 |
|